Examples of 'data in patients' in a sentence
Meaning of "data in patients"
Data in patients: This phrase typically refers to information or records related to patients, such as medical history, test results, or treatment plans
How to use "data in patients" in a sentence
Basic
Advanced
data in patients
There are no data in patients with hepatic impairment.
Patients with hepatic impairment There is no pharmacokinetic data in patients with hepatic impairment.
There is limited data in patients with cardiac impairment.
Special Populations and Conditions There are no pharmacokinetic data in patients with hypercalcaemia.
There is a lack of data in patients with renal impairment.
Data in patients with neurosyphilis are even more limited.
There is no pharmacokinetic data in patients with hepatic impairment.
Data in patients treated in the newborn ICU support this finding.
There are limited data in patients with cardiac impairment.
Data in patients with non-blood sites of infection were more limited.
There are no pharmacokinetic data in patients with impaired liver function.
Data in patients older than 65 years are limited.
No pharmacokinetic and safety data in patients with hepatic impairment are available.
Data in patients with severe renal impairment ( CLcr less than 30 mL / min ) are limited.
Pharmacokinetic data in patients.
See also
There are no data in patients with concomitant inflammatory bowel disease.
There are no adequate efficacy and safety data in patients with decompensated cirrhosis.
There are no data in patients with moderate or severe hepatic impairment.
This report should include quality of life data in patients treated with lenalidomide.
Clinical efficacy data in patients with complicated lower urinary tract infection are limited.
There are no pharmacokinetic data in patients > 75 years.
Summary of safety data in patients with previously untreated multiple myeloma.
Hepatic impairment No pharmacokinetic and safety data in patients with hepatic impairment are available.
There are limited data in patients on the interaction between serotonergic agents and tedizolid phosphate.
There are no clinical or pharmacokinetic data in patients with severe hepatic impairment Child-Pugh class C.
There are limited data in patients with malignant pleural mesothelioma treated with pemetrexed alone.
There is limited clinical data in patients aged 75 or over.
Efficacy data in patients with CML in blast crisis are not available.
There are limited clinical data in patients aged 75 or over.
There are no data in patients with severe hepatic impairment classified as Child Pugh C.
There are limited data in patients aged 75 and over.
There are no data in patients to demonstrate elimination kinetics of strontium from bone off-therapy.
There is limited pharmacokinetic data in patients with TBSA of more than 15.
There are no data in patients with confirmed slow gastric emptying or decreased motility disease / disorder.
There are very limited data in patients with a somatic BRCA mutation.
Real-world data in patients with newly diagnosed multiple myeloma (NDMM) are sparse.
Stribild has limited data in patients over the age of 65 years.
There are insufficient data in patients with moderate or severe hepatic impairment for dosing recommendations.
There are no safety data in patients older than 85 years of age.
There are limited data in patients with malignant pleural mesothelioma treated with ALIMTA alone.
There are limited clinical data in patients aged 75 years and over.
Efficacy data in patients with CML-BC are not yet available.
There are no clinical or pharmacokinetic data in patients with severe hepatic dysfunction Child-Pugh score ≥ 10.
There are no data in patients with severe hepatic impairment see section 5.2.
There are no clinical or pharmacokinetic data in patients with severe hepatic insufficiency ( Child-Pugh score > 9 ).
Long-term ( 52 week ) data in patients inadequately controlled on metformin alone or in combination with pioglitazone.
There is limited data in patients with PS ≥ 2.
There are no data in patients with severe hepatic impairment ( Child-Pugh classification C ).
Adult patients Efficacy and safety data in patients with hypophosphatasia > 18 years old are limited.
There are no data in patients with severe impairment creatinine clearance < 30 ml / min.
You'll also be interested in:
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
Examples of using Data
Show more
Select the data to display on that line
There is also evidence based on modelling data
Data on these populations are often not available